Company Legal Name
Latest Valuation
Founded Year
Headquarter
Numan operates a digital health platform specializing in personalized treatments for men's health conditions, including erectile dysfunction, hair loss, weight management, and sleep disorders. Founded in 2018 and headquartered in London, the company leverages telemedicine technology to provide discreet, accessible healthcare solutions through its online platform. Numan's approach combines clinical consultations with direct-to-consumer delivery of prescription medications and treatments, addressing traditionally underserved men's health segments. The platform targets the growing telehealth market by focusing specifically on male-oriented health issues that often carry social stigma, positioning itself within the expanding digital healthcare ecosystem serving specialized patient populations.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
